Tamur 0,4 mg Kapsułki o zmodyfikowanym uwalnianiu, twarde Lenkija - lenkų - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

tamur 0,4 mg kapsułki o zmodyfikowanym uwalnianiu, twarde

zakłady farmaceutyczne polpharma s.a. - tamsulosini hydrochloridum - kapsułki o zmodyfikowanym uwalnianiu, twarde - 0,4 mg

Solensia Europos Sąjunga - lenkų - EMA (European Medicines Agency)

solensia

zoetis belgium sa - frunevetmab - Środki przeciwbólowe - koty - for the alleviation of pain associated with osteoarthritis in cats.

Tyruko Europos Sąjunga - lenkų - EMA (European Medicines Agency)

tyruko

sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - leki immunosupresyjne - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 i 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.